These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2458480)

  • 21. Presynaptic regulation of the release of catecholamines.
    Langer SZ
    Pharmacol Rev; 1980 Dec; 32(4):337-62. PubMed ID: 6267618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha adrenergic receptors mediate angiotensin-induced prostaglandin production in the rabbit isolated vas deferens.
    Trachte GJ; Stein E; Peach MJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):433-40. PubMed ID: 3027311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors.
    Smith AB; Cunnane TC
    Br J Pharmacol; 1998 Jan; 123(2):167-72. PubMed ID: 9489603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism by nifedipine of alpha-1 and alpha-2 adrenoceptor-mediated responses of human digital arteries.
    Stevens MJ; Moulds RF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):764-9. PubMed ID: 3005555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modulation of 3,4-diaminopyridine-evoked norepinephrine release from rat hippocampal slices by activation of alpha 2-adrenoceptor].
    Huang HY; Dai SP; Xie PG
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):509-12. PubMed ID: 1284575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release.
    Allgaier C; Feuerstein TJ; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):104-9. PubMed ID: 3018592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [N-2-chloroethyl-N-ethyl-2-bromobenzylamine (DSP4) increases the liberation of 3H-noradrenaline produced by depolarization of the nerve ending].
    Landa ME; Rubio MC; Jaim-Etcheverry G
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):167-80. PubMed ID: 2847491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release and turnover of noradrenaline in isolated median eminence: lack of negative feedback modulation.
    Vizi ES; Harsing LG; Zimanvi I; Gaal G
    Neuroscience; 1985 Dec; 16(4):907-16. PubMed ID: 3005913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of age on prejunctional modulation of norepinephrine release.
    Buchholz J; Duckles SP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):159-64. PubMed ID: 2153798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential control of Ca2+-dependent [3H]noradrenaline release from rat brain slices through presynaptic opiate receptors and alpha-adrenoceptors.
    Schoffelmeer AN; Mulder AH
    Eur J Pharmacol; 1983 Mar; 87(4):449-58. PubMed ID: 6303800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of alpha 2-adrenergic inhibition of neuroeffector transmission in the mouse vas deferens.
    Illes P; Dörge L
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):241-7. PubMed ID: 2984583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low temperature prevents potentiation of norepinephrine release by phenylephrine.
    Santha E; Lendvai B; Gerevich Z
    Neurochem Int; 2001 Mar; 38(3):237-42. PubMed ID: 11099782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of a Ca2+-dependent K+ channel in brown adipocytes. Possible role in maintenance of alpha 1-adrenergic stimulation.
    Nånberg E; Connolly E; Nedergaard J
    Biochim Biophys Acta; 1985 Jan; 844(1):42-9. PubMed ID: 2578297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A difference in alpha-adrenoceptor mechanisms in vasa deferentia isolated from young and old rats.
    Takayanagi I; Koike K; Maeda O; Ishizuka M
    Jpn J Pharmacol; 1986 Aug; 41(4):533-6. PubMed ID: 3022050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin modulation of [3H]noradrenaline release from superfused hypothalamic slices.
    Beresford IJ; Hall MD; Clark CR; Hill RG; Hughes J
    Neurosci Lett; 1988 May; 88(2):227-32. PubMed ID: 2837695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mono- and diaminopyridines on release of [3H]norepinephrine from isolated guinea-pig atrium.
    Sugimori T; Nagashima H; Vizi ES; Harsing LG; Chaudhry I; Lalezari I; Duncalf D; Goldiner PL; Foldes FF
    Neuropharmacology; 1987 Jun; 26(6):621-6. PubMed ID: 3037424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allopregnanolone-induced modification of presynaptic basal and K+-induced [3H]-norepinephrine efflux from rat cortical slices during the estrous cycle.
    Belmar J; Cuellar C; Llona I; Arancibia S; Kusch C; Tapia-Arancibia L; Pinter A; Pérez H
    Neuroendocrinology; 1998 Oct; 68(4):264-71. PubMed ID: 9772341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the role of Na+, K+ and Cl- ion permeabilities in K+-induced release of 3H-noradrenaline from rat brain slices and synaptosomes and in its presynaptic alpha-adrenergic modulation.
    Wemer J; Schoffelmeer AN; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):103-9. PubMed ID: 6272131
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium- and potassium-channel blockers interact with alpha-adrenoceptors.
    Glossmann H; Hornung R
    Mol Cell Endocrinol; 1980 Sep; 19(3):243-51. PubMed ID: 6250930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of potassium channel blockers.
    Tepper JM; Sawyer SF; Young SJ; Groves PM
    Brain Res; 1986 Mar; 367(1-2):230-7. PubMed ID: 2421831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.